Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03499119 · ClinicalTrials.gov registry record · Phase 1
AMG 334 20160172 Pediatric Migraine PK Study.
A Phase 1 study, sponsored by Amgen.
- Completed
- Registry status
- Phase 1
- Development phase
- 53
- Enrollment target
NCT03499119 is a Phase 1 study that has completed, run by Amgen. The registered enrollment target is 53 participants.
The verdict
NCT03499119, a Phase 1 study, has completed, sponsored by Amgen.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 53 participants
- Enrollment target
Study Summary
AMG 334 20160172 Pediatric Migraine PK Study.
Interventions
- DRUG AMG 334 Dose 1
- DRUG AMG 334 Dose 2
- DRUG AMG 334 Dose 3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2018-05-04 |
| Est. Completion | 2021-11-23 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03499119
The ClinicalTrials.gov registry entry for NCT03499119 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Amgen, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which AMG 334 Dose 1 is the first listed.
NCT03499119 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03499119 about?
NCT03499119 is a clinical study titled "AMG 334 20160172 Pediatric Migraine PK Study.". AMG 334 20160172 Pediatric Migraine PK Study.
What is the current status of trial NCT03499119?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 53 participants. The study started on 2018-05-04. Estimated completion is 2021-11-23.
What interventions are being tested in trial NCT03499119?
The interventions under investigation include: AMG 334 Dose 1 (DRUG), AMG 334 Dose 2 (DRUG), AMG 334 Dose 3 (DRUG).
Who is sponsoring clinical trial NCT03499119?
This trial is sponsored by Amgen, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.